Photo: Depositphotos
Jul 25, 2025, 14:18
Devika Das: A Phenomenon Known as Pseudo-Acute Kidney Injury
Devika Das, Associate Professor of Medicine at the University of Florida College of Medicine, shared a post on LinkedIn about recent paper she and colleagues co-authored published in Journal of Clinical Oncology.
“Several TKIs can inhibit OCT2 and MATE1, leading to elevated serum creatinine levels without affecting the GFR, a phenomenon known as pseudo-acute kidney injury. Sharing our correspondence regarding the same- highlighting this clinical challenge.
Cystatin C clearance helps in testing: pearl for SOC and clinical trials.”
Title: Afatinib, Dose Reduction, and Pseudo-Acute Kidney Injury
Authors: Jacqueline Nguyen, Devika Das, Chintan V. Shah
Read The Full Article at Journal of Clinical Oncology.
More posts featuring Devika Das.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 25, 2025, 22:02
Jul 25, 2025, 21:34
Jul 25, 2025, 21:01
Jul 25, 2025, 20:41
Jul 25, 2025, 20:07
Jul 25, 2025, 19:11
Jul 25, 2025, 17:20